Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Indianapolis, IN
SEC filing record 1 source field available
Fiscal year end
31 December
POINT Biopharma Global Inc. has filed 285 SEC EDGAR filings since 14 May 2020

SEC filing history

Showing 1-25 of 285 matching filings.

Per page
25
Current page
1
15-12G File 001-39373

15-12G

Filing date
08 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-265981

EFFECT filing

Filing date
29 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-254600

EFFECT filing

Filing date
29 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2023
Reporting date
26 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2023
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2023
Reporting date
22 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2023
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2023
Reporting date
22 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2023
Reporting date
26 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2023
Reporting date
26 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2023
Reporting date
26 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2023
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2023
Reporting date
22 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2023
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91575

SC 13D/A

Filing date
27 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-254600

POS AM

Filing date
27 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-265981

POS AM

Filing date
27 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-273965

S-8 POS

Filing date
27 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-266812

S-8 POS

Filing date
27 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-259171

S-8 POS

Filing date
27 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-39373

25-NSE filing

Filing date
27 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-91575

SC 14D9/A

Filing date
26 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-91575

SC TO-T/A

Filing date
26 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Dec 2023
Reporting date
18 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .